{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:32:53Z","timestamp":1762252373354},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.urology.2016.05.030","type":"journal-article","created":{"date-parts":[[2016,5,22]],"date-time":"2016-05-22T02:56:29Z","timestamp":1463885789000},"page":"314.e1-314.e7","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract"],"prefix":"10.1016","volume":"94","author":[{"given":"Jay D.","family":"Raman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua I.","family":"Warrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Shuman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Bruggeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon Z.","family":"Weizer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesut","family":"Remzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Haitel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Bensalah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Rioux-Leclerq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bolenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Roscigno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura-Maria","family":"Krabbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Payal","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaly","family":"Margulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"DeGraff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2016.05.030_bib0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.hoc.2014.10.003","article-title":"Diagnosis and management of upper tract urothelial carcinoma","volume":"29","author":"Lucca","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.urology.2016.05.030_bib0015","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2016.05.030_bib0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00345-011-0710-3","article-title":"Predictive factors of recurrence and survival of upper tract urothelial carcinomas","volume":"29","author":"Verhoest","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2016.05.030_bib0025","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2217\/epi.15.34","article-title":"Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma","volume":"7","author":"Xiong","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.urology.2016.05.030_bib0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cdd.2008.116","article-title":"FOXA1 and IRF-1 intermediary transcriptional regulators of PPARgamma-induced urothelial cytodifferentiation","volume":"16","author":"Varley","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.urology.2016.05.030_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036669","article-title":"Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation","volume":"7","author":"DeGraff","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.urology.2016.05.030_bib0040","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ajpath.2015.01.014","article-title":"Loss of FOXA1 drives sexually dimorphic changes in urothelial differentiation and is an independent predictor of poor prognosis in bladder cancer","volume":"185","author":"Reddy","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.urology.2016.05.030_bib0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.urology.2016.05.030_bib0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.eururo.2013.12.008","article-title":"Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma","volume":"66","author":"Lee","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.05.030_bib0055","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/labinvest.2014.64","article-title":"FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype","volume":"94","author":"DeGraff","year":"2014","journal-title":"Lab Invest"},{"key":"10.1016\/j.urology.2016.05.030_bib0060","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/pros.20299","article-title":"Expression and role of Foxa proteins in prostate cancer","volume":"66","author":"Mirosevich","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2016.05.030_bib0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/pros.20131","article-title":"Expression of Foxa transcription factors in the developing and adult murine prostate","volume":"62","author":"Mirosevich","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2016.05.030_bib0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1309\/AJCP1RF9FUIZRDPI","article-title":"Interobserver concordance in implementing the 2010 ASCO\/CAP recommendations for reporting ER in breast carcinomas: a demonstration of the difficulties of consistently reporting low levels of ER expression by manual quantification","volume":"140","author":"Reisenbichler","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.urology.2016.05.030_bib0080","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2016.05.030_bib0085","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.eururo.2011.12.055","article-title":"Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma","volume":"61","author":"Rink","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.05.030_bib0090","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.urolonc.2011.07.017","article-title":"When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression","volume":"31","author":"DeGraff","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2016.05.030_bib0095","doi-asserted-by":"crossref","first-page":"244ra291","DOI":"10.1126\/scitranslmed.3008970","article-title":"EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype","volume":"6","author":"Rebouissou","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.urology.2016.05.030_bib0100","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.eururo.2015.07.039","article-title":"Genomic characterization of upper tract urothelial Carcinoma","volume":"68","author":"Sfakianos","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.05.030_bib0105","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.eururo.2015.08.034","volume":"69","author":"McConkey","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2016.05.030_bib0110","first-page":"155","article-title":"Prognostic and predictive factors in breast cancer by immunohistochemical analysis","volume":"11","author":"Allred","year":"1998","journal-title":"Mod Pathol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951630228X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951630228X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T13:17:08Z","timestamp":1620825428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042951630228X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":20,"alternative-id":["S009042951630228X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2016.05.030","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2016.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}